Search Results 91-100 of 16623 for Certolizumab

  1. Infliximab-axxq (intravenous route) - Side effects & uses - Mayo Clinic

    Azathioprine; Bacillus of Calmette and Guerin Vaccine, Live; Baricitinib; Brodalumab; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue ...

  2. Treating Breast Cancer Patients Undergoing Trastuzumab Treatment with Carvedilol to Reduce Incidence of Heart Failure - Mayo Clinic

    The purpose of this study is to evaluate different strategies of cardiovascular therapy with Carvedilol, aiming to reduce the incidence of left ventricular ...

  3. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    Has not previously received an approved biologic for CD (i.e., infliximab, adalimumab, certolizumab pegol, ustekinumab, natalizumab, vedolizumab or approved ...

  4. A Study To Collect Biospecimens (Blood, Stool And Intestinal Biopsies) To Support The Development Of Specific Biomarkers Of Treatment Response To Infliximab And Vedolizumab In Children With IBD - Mayo Clinic

    ... certolizumab pegol, golimumab or any anti-TNFαbiosimilar). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

  5. A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma [IMmotion150] - Mayo Clinic

    A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...

  6. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment, epratuzumab ...

  7. Adalimumab-aqvh (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Etanercept; Golimumab ...

  8. Cancer Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of pazopanib hydrochloride in treating patients with solid tumors that has spread to other places ...

  9. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

    Monoclonal antibodies, such as atezolizumab and bevacizumab, may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such ...

  10. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth. Androgen may cause the growth of tumor cells. Enzalutamide may stop the growth of ...